| 2922.49.10 | 00 | m-Aminobenzoic acid, technical; p-Aminobenzoic acid; 3,5-Diaminobenzoic acid; 2-Ethylamino-5-sulfobenzoic acid; 3-(N-Ethylanilino)propionic acid, methyl ester; β-( β-Methoxyethoxyethyl)-4-aminobenzoate; Methyl anthranilate; and l-Phenylalanine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.49.26 | 00 | Drugs | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 45% |
| 2922.49.30 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 50% |
| 2922.49.40 | | Amino acids | | 4.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2922.49.40 | 10 | Alanine | kg | | | |
| 2922.50.13 | 00 | Isoetharine hydrochloride; Isoxsuprine hydrochloride; Nylidrin hydrochloride; Phenylephrine hydrochloride; Salbutamol (Albuterol); and Terbutaline sulfate | kg | Free | | 15.4￠/kg + 47% |
| 2922.50.14 | 00 | Cardiovascular drugs | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 65% |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2922.50.19 | 00 | Guaiacol derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 79% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 50% |
| 2923.10.00 | 00 | Choline and its salts | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.19.11 | | Amides | | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.19.11 | 10 | Acrylamide | kg | | | |
| 2924.19.11 | 20 | Dimethylformamide | kg | | | |
| 2924.19.11 | 30 | Methacrylamide | kg | | | |
| 2924.21.12 | 00 | 1-(2-Methylcyclohexyl)-3-phenylurea | kg | Free | | 15.4￠/kg + 48.5% |
| 2924.21.18 | 00 | sym-Diethyldiphenylurea | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.29.01 | 00 | p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamide | kg | Free | | 15.4￠/kg + 39.5% |
| 2924.29.03 | 00 | 3,5-Dinitro-o-toluamide | kg | Free | | 15.4￠/kg + 47.5% |
| 2924.29.10 | 00 | Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)aniline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 53% |
| 2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4￠/kg + 58% |
| 2924.29.26 | 00 | 3-Aminomethoxybenzanilide | kg | Free | | 15.4￠/kg + 54.5% |
